Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis by Verschoyle, R D et al.
Evaluation of the cancer chemopreventive efficacy of rice bran in
genetic mouse models of breast, prostate and intestinal
carcinogenesis
RD Verschoyle
1, P Greaves
1, H Cai
1, RE Edwards
2, WP Steward
1 and AJ Gescher*,1
1Cancer Biomarkers and Prevention Group, Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE2 7LX, UK;
2Medical Research Council Toxicology Unit, University of Leicester, Leicester, UK
Brown rice is a staple dietary constituent in Asia, whereas rice consumed in the Western world is generally white, obtained from
brown rice by removal of the bran. We tested the hypothesis that rice bran interferes with development of tumours in TAg,
TRansgenic Adenocarcinoma of the Mouse Prostate (TRAMP) or Apc
Min mice, genetic models of mammary, prostate and intestinal
carcinogenesis, respectively. Mice received rice bran (30%) in AIN-93G diet throughout their post-weaning lifespan. In TAg and
TRAMP mice, rice bran did not affect carcinoma development. In TRAMP or wild-type C57Bl6/J mice, dietary rice bran increased
kidney weight by 18 and 20%, respectively. Consumption of rice bran reduced numbers of intestinal adenomas in Apc
Min mice by 51%
(Po0.01), compared to mice on control diet. In parallel, dietary rice bran decreased intestinal haemorrhage in these mice, as reflected
by increased haematocrit. At 10% in the diet, rice bran did not significantly retard Apc
Min adenoma development. Likewise, low-fibre
rice bran (30% in the diet) did not affect intestinal carcinogenesis, suggesting that the fibrous constituents of the bran mediate
chemopreventive efficacy. The results suggest that rice bran might be beneficially evaluated as a putative chemopreventive
intervention in humans with intestinal polyps.
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Cancers of the colorectum, breast and prostate constitute major
human malignancies for which effective and safe chemoprevention
strategies are scarce. Undoubtedly, several recent clinical results
validate the conceptual feasibility of cancer chemoprevention in
humans. These findings bear out that nonsteroidal anti-inflam-
matory drugs such as aspirin (Baron et al, 2003) or selective
inhibitors of cyclooxygenase-2 (COX-2) (Steinbach et al, 2000)
interfere with colorectal malignancies, that selective oestrogen
receptor modulators such as tamoxifen can prevent breast cancer
(Fisher et al, 1998) and that the a-reductase inhibitor finasteride
can delay the onset of prostate cancer (Thompson et al, 2003).
However, chemopreventive interventions using drugs have raised
safety concerns. For example, the recent realisation that long-term
administration of selective COX-2 inhibitors can detrimentally
affect the cardiovascular system, resulting in an increased risk of
stroke or cardiac infarction (Fitzgerald, 2004), has dampened the
enthusiasm for their extensive use as cancer chemopreventive
interventions. Safety problems intrinsic to drugs administered
over prolonged periods of time strengthen the interest in diet-
related cancer chemoprevention approaches. Epidemiological
evidence suggests that human consumption of whole-grain foods
may be associated with a low incidence of cancer, especially in
the colorectum (Witte et al, 1996; World Cancer Research Fund,
1997). Rice, Oryza sativa, is the staple food of over half the world’s
population. The unpolished brown (bran-containing) variety
possesses special dietary importance in Asia. Rice consumed in
the Western world is generally white and is obtained from brown
rice by removal of the bran. Dietary differences such as this
may explain why the incidence of cancers, including those of the
colorectum, breast and prostate is much lower in Asia than in the
Western world (Witte et al, 1996). Rice bran contains agents
believed to possess cancer chemopreventive properties that are
absent from the white variety. Preclinical evidence for anti-
carcinogenic properties of rice bran, or any of its constituents, is
scarce. Promising cancer chemoprevention strategies can suitably
be tested in genetic animal models of carcinogenesis by evaluating
changes in incidence, multiplicity or volume of preneoplastic and/
or neoplastic lesions. In the C3(1) SV40 T,t antigen transgenic
multiple mammary adenocarcinoma (TAg) mouse, a model of
breast carcinogenesis, expression of the SV40 transforming
sequences (T and t antigen) is targeted to the mammary epithelium
by a fragment of the rat prostatic steroid-binding protein promoter
C3(1) (Maroulakou et al, 1994). The T-antigen binds and
functionally inactivates p53 and Rb tumour-suppressor genes
(Dyson et al, 1989; Mietz et al, 1992). The consequent perturbation
of cell homeostasis is thought to be responsible for mammary
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scarcinogenesis, and all female TAg mice develop palpable tumours
from approximately 12 weeks of age (Maroulakou et al, 1994). A
similar genetically modified rodent species is the ‘TRansgenic
Adenocarcinoma of the Mouse Prostate’ (TRAMP) model, in which
expression of the SV40 transforming sequences is targeted to the
prostate by a prostate-specific rat probasin promoter (Greenberg
et al, 1995). All male TRAMP mice develop prostate cancer from
approximately 18 weeks of age (Gingrich et al, 1999). The Apc
Min
mouse is a model of gastrointestinal carcinogenesis genetically
driven by a truncating Apc gene mutation (Luongo et al, 1994), and
it resembles the human heritable condition, familial adenomatous
polyposis coli (FAP). Among diet-derived agents that have been
found to impede carcinogenesis in these models are tea prepara-
tions, which interfered with carcinogenesis in TRAMP (Gupta et al,
2001) and TAg mice (Kaur, Greaves, Cooke, Edwards, Steward,
Gescher and Marczylo, submitted), and the yellow spice curcumin,
which compromised adenoma development in Apc
Min mice
(Mahmoud et al, 2000; Perkins et al, 2002). In the light of the
putative health benefit, which might be derived from rice bran,
we tested the hypothesis that its consumption interferes with
breast, prostate or intestinal carcinogenesis in the TAg, TRAMP or
Apc
Min mouse models. We found that rice bran reduced adenoma
development in the Apc
Min mouse, and dissected the role which the
nonfibrous components of the bran preparation may play in
mediating chemopreventive activity by studying the effect of low
fibre rice bran.
MATERIALS AND METHODS
Animals
Breeding colonies were established with: (i) TAg mice on an FVB
background, (ii) TRAMP mice on a C57BL/6J background and (iii)
C57BL/6J Min/þ (Apc
Min) mice. Mice were bred in the Leicester
University Biomedical Services facility using animals originally
obtained from either the Jackson Laboratory (Bar Harbor, ME,
USA, Apc
Min and TAgs) or the NCI Mouse Repository (NCI
Frederick Rockville, MD, USA, TRAMP). Ear tissue from newborn
mice was genotyped for the presence of the transgene using PCR,
as described previously (Maroulakou et al, 1994; Perkins et al,
2002; The Jackson Laboratory website: www.jax.org).
Rice bran
Two stabilised rice bran preparations (‘Rice X Stabilized Rice Bran
– Regular’ and ‘Rice X Solubles’), produced by the Rice X Comp (El
Dorado Hills, CA, USA), were either purchased from Alexander
Essentials (Morecambe, UK) or obtained as a gift from the RiceX
Comp. ‘Rice X Stabilized Rice Bran – Regular’, referred to in the
following as ‘rice bran’, is produced by milling brown rice, a
process which releases an active lipase. The milling process
includes a ‘stabilisation’ step involving elevated temperature and
pressure to ensure lipase deactivation. According to the providers’
product data sheet, ‘Rice X Stabilized Rice Bran – Regular’
contains (all values expressed per 100g rice bran) 29g dietary
fibre, 15g protein, 21g fat and 22g available carbohydrate. This
bran preparation contains the following vitamins and minerals:
carotenoids (129mg), vitamin B complex (57mg), vitamin E
complex (26mg), folic acid (27mg), biotin (14mg), choline
(105mg), inositol (1496mg) g-oryzanol (245mg), phytosterols
(341mg), sodium (8mg), potassium (1573mg), calcium (40mg),
magnesium (727mg), phosphorus (1591mg), manganese (26mg),
iron (8mg) and zinc (6mg). ‘Rice X Solubles’ (referred to in the
following as ‘low-fibre rice bran’) is a powdered emulsion of
soluble stabilised rice bran omitting insoluble fibre. It contains (all
values per 100g rice bran) 3g dietary fibre, 8g protein, 27g fat and
55g available carbohydrate. This bran preparation contains the
following vitamins and minerals: carotenoids (47mg), vitamin B
complex (92mg), vitamin E complex (18mg), folic acid (37mg),
biotin (15mg), choline (150mg), inositol (1314mg), g-oryzanol
(248mg), phytosterols (413mg), sodium (16mg), potassium
(1562mg), calcium (8mg), magnesium (171mg), phosphorus
(763mg), manganese (3mg), iron (2mg) and zinc (2mg).
Animal experiments
Experiments were carried out under animal project licence PPL
40/2496, granted to Leicester University by the UK Home Office.
The experimental design was vetted by the Leicester University
Local Ethical Committee for Animal Experimentation and met the
standards required by the UKCCCR guidelines (Workman et al,
1998). Groups of 10–16 mice at 4 weeks of age received standard
AIN 93G diet or AIN diet supplemented with rice bran (30 or 10%)
to the end of the animals’ life. No attempt was made to adjust
nutritional components of the AIN93 diet to compensate for the
addition of rice bran. The calorific values of AIN 93 G diet or AIN
diet containing 30% rice bran or 30% low-fibre rice bran were 377,
363 and 410 calories, respectively, per 100g diet (based on Reeves
et al, 1993, and the rice bran provider’s product data sheets).
Addition of rice bran decreased the protein and carbohydrate
content of the overall diet slightly, and increased the fat content
from 7% in control AIN diet to 11% for the diet containing
30% rice bran and to 14% for the low-fibre rice bran diet (30%).
From 11 weeks of age, TAg and TRAMP mice were palpated once
or twice weekly for presence of tumours. TAg tumour size was
measured using callipers, and tumour volume was calculated using
the equation:V¼0.5236 D d
2, with D and d representing the
long and the short diameters, respectively. Animals were killed
by cardiac exsanguination (halothane anaesthesia) in weeks 18
(Apc
Min), 19 (TAg) or 34 (TRAMP). The intestinal tract of Apc
Min
mice was removed and flushed with phosphate-buffered saline.
Intestinal tissue was cut open longitudinally and examined under a
magnifying lens. Multiplicity, location and size of adenomas were
recorded as described before (Perkins et al, 2002).
Packed red cell volume (haematocrit) was measured as
described before (Strumia et al, 1954). Tumours in TAg mice,
prostate with prostate tumour plus seminal vesicles, livers, kidneys
and lungs of wild-type C57BL6/J or TRAMP mice were excised,
weighed and placed in buffered formalin (for histopathology).
Histopathology
The following tissues were fixed in formalin for a minimum of 2
weeks: the pelt from TAg mice, the intestinal tract from Apc
Min
mice, the prostate with prostate tumour plus seminal vesicles and
lungs, liver, salivary glands, kidney, spleen, pancreas, gut and
dorsal abdominal connective tissue, including inguinal and lumbar
lymph nodes from TRAMP mice or wild-type mice. TAg mouse
pelts were cut to yield five transverse blocks corresponding to
the five pairs of mammary glands. All tissues were embedded in
paraffin wax and sections (5mm thick) were cut and stained with
haematoxylin and eosin before microscopic examination. For
estimation of numbers of microadenomatous crypts in the
colorectum of Apc
Min mice, the formalin-fixed colorectal tract
was placed in 0.5% aqueous methylene blue solution (20s). Excess
stain was removed (water), and tissue was flattened between two
microscope slides (held in place with elastic bands) and scanned
microscopically.
Statistical evaluation
Evaluation of significance of values, as compared to the appro-
priate controls, was performed by either one-way analysis of
variance with subsequent Tukey’s pairwise comparison or a
two-sample Student’s t-test.
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sRESULTS
Effect of rice bran on murine body weight
TAg, TRAMP, their C57Bl/6J wild-type counterparts and Apc
Min
mice received rice bran in their diet (30%, B0.9g per
mouse¼B36gkg
 1 per day) from weaning until the end of the
experiment, which was week 18 for the Apc
Min mice, week 19 for
the TAg mice and week 34 for the TRAMP mice. Figure 1 shows
that the animals’ body weight was not significantly different
from that of mice on the control diet. There is an indication
that TRAMP, wild-type C57Bl/6J and female Apc
Min mice on rice
bran were marginally heavier than those on AIN diet alone
(Figure 1B, C). Overall, this result suggests that rice bran in the diet
does not adversely affect food intake.
Effect of rice bran on TAg and TRAMP mice
On histopathological investigation, TAg mice presented with intra-
duct hyperplasia, intra-duct carcinoma and invasive mammary
carcinoma, occasional intra-duct papillomas were also present. In
TRAMP mice, proliferative lesions in the prostate formed a
continuum between increasing degrees of glandular hyperplasia
with atypical cytological features through to frank adenocarcinoma
without clearly defined nodular benign neoplasia or adenoma.
These observations are consistent with the original description of
the TAg and TRAMP mouse models (Maroulakou et al, 1994;
Gingrich et al, 1999). There was no clear difference between
control and treated mice with respect to TAg or TRAMP tumour
histopathology.
Consumption of bran failed to significantly affect mammary
carcinogenesis in TAg mice, as reflected by survival of animals
(Figure 2A), tumour volume (Figure 2B), number of tumours per
mouse (Figure 2C) or tumour weight at the end of the experiment
(Figure 2D). The results shown in Figure 2B and D tentatively hint
at slightly increased tumour weight and volume in TAg mice on
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Figure 1 Effect of rice bran on whole body weight of TAg mice (A), TRAMP mice and their wild-type (C57Bl/6J) counterparts (B)o rApc
Min mice (C).
Mice received control diet or diet fortified with rice bran at 30%. Results are the mean7s.d. of 12–16 mice. For details of animal experimentation, see
Materials and methods.
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Figure 2 Lack of effect of rice bran on mammary carcinogenesis in TAg
mice as reflected by survival (A), tumour volume (B), tumour multiplicity
(C) and tumour weight (D). Mice received control diet (open bars) or 30%
rice bran in the diet (closed bars) from week 3 after weaning for their
lifetime. Animals were killed when tumour diameter exceeded 17mm.
Volume, multiplicity and weights of tumours were determined at the
termination of the experiment. Results are the mean7s.d. (n¼12 for
controls and 15 for intervention group). For details of experimental design
and assessment of TAg tumour development see Materials and methods.
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srice bran compared to controls. Rice bran consumption did not
interfere with prostate carcinogenesis in TRAMP mice, as mirrored
by tumour weight at the end of the experiment (Figure 3A).
Healthy prostate, liver, kidney, lung spleen, lymph nodes,
pancreas and gut tissues in TRAMP and wild-type C57Bl/6J mice
were closely inspected for potential effects of rice bran. The weight
of healthy prostate in C57BL/6J (Figure 3B) and of liver and lung
in wild-type C57BL/6J or TRAMP mice (Figure 3C and D) was not
affected by rice bran consumption. Livers in TRAMP mice weighed
significantly less than those in wild-type mice, irrespective of diet
(Figure 3C). For mice on control diet, the difference was 18% and
for mice on rice bran 13%. These livers showed variable degree of
clear cell change (glycogen) and vacuolation (fat) typical of well-
fed mice without clear histological differences between rice bran-
fed and control mice. Kidneys in wild-type or TRAMP mice that
received 30% rice bran weighed 20 or 18%, respectively, more than
kidneys in mice on control diet (Figure 3E). On histopathological
inspection, large clear vacuoles, indicative of lipid droplets without
evidence of cellular degeneration, were present in the proximal
tubular cell cytoplasm in all mice, albeit more prominently in the
mice that received rice bran.
Effect of rice bran on intestinal adenoma development in
Apc
Min mice
Histopathological analysis of the small intestine of Apc
Min mice,
which had received control diet or rice bran (30%) during their life
time, showed focal proliferative lesions ranging from hyperplastic
glands to larger areas of glandular hyperplasia and polypoid
adenomas. There were no significant differences in tumour
morphology in terms of dysplasia between control mice and mice
on rice bran, which suggests that there was no difference in
tumour aggressiveness. The numbers of adenomas in the small
intestine or colon of mice on rice bran were significantly reduced
by 51 and 32%, respectively, compared to mice on control diet
(Figure 4A and B). A detailed analysis of small intestinal polyp
location revealed that polyp numbers in the proximal, middle and
distal sections of the intestine were similarly affected by rice bran
(Figure 5A). The effect of bran on adenoma development was more
notable in small and medium-sized polyps (o3mm) than in large
ones (43mm) (Figure 5B), even though the overall small number
of large polyps observed may have obfuscated any difference. At
the late stage of adenoma development, Apc
Min mice suffer from
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Figure 3 Effect of rice bran on weight of the following tissues in TRAMP mice (A, C–E) or C57Bl/6J (wild-type) mice (B–E): prostate carcinoma plus
seminal vesicles (A), normal prostate plus seminal vesicles (B), liver (C), lung (D) and kidney (E). Mice received control diet (open bars) or diet fortified with
30% rice bran (closed bars) from weaning for their lifetime. Tissue weight was determined at the termination of the experiment. Results are the mean7s.d.
of 12–16 mice. Stars indicate that liver weight in TRAMP mice was significantly lower than that in wild-type mice (*Po0.02, **Po0.005), and crosses
indicate that kidney weights in mice on rice bran were significantly higher than those in mice on control diet (
þþPo0.002). For details of experimental
design and assessment of tissue weight, see Materials and Methods.
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Figure 4 Effect of 30% dietary rice bran on adenoma number in the
small intestine (A) or colon (B) and on haematocrit (C)i nApc
Min mice.
Mice received control diet (open bars) or diet fortified with 30% rice bran
(closed bars) from week 3 after weaning for their lifetime. Results are the
mean7s.d., n¼15. Stars indicate that value is significantly different from
control (*Po0.05, **Po0.01, ***Po0.001). For details of experimental
design and assessment of adenoma number, see Materials and Methods.
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sintestinal bleeding, which causes a dramatic fall in haematocrit.
Intervention with rice bran raised the haematocrit measured at
the end of the experiment, from 22.2% in untreated Apc
Min mice
to 33.1%, consistent with impeded adenoma development
(Figure 4C). In order to test the hypothesis that a smaller dose
of rice bran may affect adenoma development, the experiment was
repeated by including mice on 10% dietary rice bran. In this repeat
experiment, rice bran at 30% reduced small intestinal adenoma
load by 45% (from 40711 per mouse to 22715, mean7s.d.,
n¼15–17, Po0.005) and colonic adenomas by 31% (from
3.271.5 to 2.271.1, Po0.05), in accordance with the results
shown in Figure 4. In contrast, small intestinal or colonic adenoma
numbers were not significantly diminished by 10% rice bran
(Figure 6A and B). Consistent with these results, the haematocrit in
Apc
Min mice on 30% rice bran (28.679.9%) was significantly
higher than that in mice on the control diet (17.777.6%,
P¼0.002), whereas 10% rice bran did not significantly increase
the haematocrit compared to controls (Figure 6C).
In order to explore whether nonfibrous-constituents of rice bran
mediate the retardation of adenoma development, Apc
Min mice
received a low-fibre rice bran preparation with their diet at the
same dose (30%), at which high-fibre rice bran reduced adenomas.
The numbers of adenomas in the small intestine and colon of mice
on low-fibre rice bran were not significantly different from those
in mice on control diet (Figure 6A and B), and the haematocrit
reflected the lack of effect of low-fibre rice bran on adenoma
development (Figure 6C). Thus, in contrast to high-fibre-contain-
ing rice bran, low-fibre rice bran failed to affect adenoma
formation.
It has been suggested that numbers of microadenomatous crypts
in the colorectal tract of Apc
Min mice might allow a judgment to be
made as to the effect of potential chemopreventive interventions,
in a fashion arguably more relevant to the human disease
counterpart than by counting adenomas in the small intestine
(Yamada et al, 2002). When we enumerated the microadenoma-
tous crypts identifiable in the colorecta of Apc
Min mice in this
experiment, 16 of the 51 mice (31%) had a total of 37
microadenomatous crypts. Individually, the mice displayed
between one and seven lesions, far fewer than the 420 lesions
per mouse observed by Yamada et al (2002). There was no
difference in propensity between mice on control diet and those on
rice bran to bear microadenomatous crypts.
DISCUSSION
The results presented here suggest for the first time, that while rice
bran possesses cancer chemopreventive efficacy in the Apc
Min
mouse model of colorectal carcinogenesis, it lacks anticarcinogenic
activity in the TAg or TRAMP mouse models of mammary and
prostate cancer. The fat content of the rice bran preparation may
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Figure 6 Lack of effect of 10% dietary rice bran (closed bars) or 30% dietary low-fibre rice bran (crossed bars) on adenoma number in the small intestine
(A) or colon (B) and on haematocrit (C)i nApc
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assessment of adenoma number, see Materials and Methods.
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Figure 5 Effect of dietary 30% dietary rice bran on adenoma multiplicity
in the proximal (‘prox’), middle and distal sections of the small intestine (A),
and on total multiplicity of small (o1mm diameter), medium-sized (1–
3mm) or large (43mm) adenomas (B)i nApc
Min mice. Mice received
control diet (open bars) or diet containing 30% rice bran (closed bars) from
week 3 after weaning for their lifetime. Results, which are presented as
number of adenomas per mouse as related to distribution (A) or size (B),
are the mean7s.d. (n¼15). Stars indicate that values are significantly
different from controls (*Po0.05, **Po0.01, ***Po0.005). For details of
experimental design and assessment of adenoma number, see Materials
and Methods.
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shave caused the observed slight elevation compared to controls of
TAg mouse tumour weight and volume; and of bodyweight of
TRAMP, wild-type C57Bl6/J and female Apc
Min mice. The results
also suggest that the adenoma-retarding activity of rice bran was
dose-related, that it was exerted evenly along all sections of the
murine intestinal tract, and that activity was associated predomi-
nantly with the fibre content of the bran rather than the nonfibrous
constituents. These results, obtained in three genetic carcinogen-
esis models, contribute to the emerging preclinical evidence that
brown rice products possess cancer chemopreventive properties
in rodents. Evidence for potential benefit seems to accumulate
especially in colorectal carcinogenesis models. Rice germ (2.5% in
the diet), and Kurosu, a vinegar generated from unpolished rice,
prevented azoxymethane-induced colon carcinogenesis in rats
(Kawabata et al, 1999; Shimoji et al, 2004). A brown rice
preparation (2.5 or 5% in the diet), obtained by fermentation
with Aspergillus oryzae, interfered with azoxymethane-induced
formation of aberrant crypt foci and adenocarcinomas in rats
(Katayama et al, 2002). Furthermore, fermented brown rice
reduced diethylnitrosamine- and phenobarbital-induced hepato-
carcinogenesis in rats (Katayama et al, 2003), N-nitrosomethyl-
benzylamine-induced oesophageal tumorigenesis in rats (Kuno
et al, 2004) and bladder carcinogenesis in mice (Kuno et al, 2006).
To our knowledge there is no information in the literature on the
epidemiology, linking consumption of brown rice or rice bran to
colorectal cancer risk in humans, which would complement the
available data in animal models.
The result described here in the Apc
Min mouse is consistent with
reports on the effect of rye bran (10% in the diet administered for
5–6 weeks, Mutanen et al, 2000) and wheat bran (5–20% for 7–9
weeks, Hioki et al, 1997; Yu et al, 2001), which have previously
been shown to reduce adenoma development in this model.
Molecules in the rice bran fibre fraction, which may have
contributed to inhibition of adenoma formation observed here in
the Apc
Min mouse, are the carbohydrates dextran-like a-glucan and
arabinoxylan hemicellulose, both of which have previously been
suggested to possess cancer chemopreventive properties (Takeo
et al, 1988; Takenaka and Takahashi, 1991; Aoe et al, 1993). In
principle there are three types of mechanism by which dietary fibre
is thought to interfere with colorectal carcinogenesis (for review,
see Young et al, 2005), and they may also be germane to rice bran
fibre. These mechanisms have been the subject of much
investigation, although details and their relative importance are
unresolved. Firstly, fibre is thought to exert ‘physical’ effects such
as increasing faecal bulk, hastening faecal transit and binding
potentially co-carcinogenic bile salts. Secondly, fibre can change
the gastrointestinal microflora and luminal environment in such a
way as to alter bacterial species, that may, in turn, reduce bile salt
metabolism. Thirdly, fibre carbohydrates can undergo fermenta-
tion in the luminal environment, generating short chain fatty
acids such as butyrate, which are thought to exert anticarcinogenic
effects such as inhibition of cell proliferation and induction of
differentiation and apoptosis. The lack of effect of rice bran on
carcinogenesis, in the genetic models of mammary and prostate
cancer described here, is consistent with the fact that it was the
fibre fraction of the bran which mediated the anticarcinogenic
effects in the Apc
Min mouse, and that fibre components would be
unlikely to reach organs remote from the gastrointestinal tract.
The rice bran dose in humans that would be equivalent to the
30% dietary dose (B36gkg
 1 pd), which was active in the mice
described here, when calculated on the basis of equivalent body
surface area, would be 115gm
 2 or 207g per person pd, assuming
a body surface area of 1.8m
2 accompanying a body weight of 70kg
(Freireich et al, 1966). Although this is a hefty dose, it is feasible
and very probably safe. In our study, a preliminary investigation
of effects of 30% dietary rice bran on the murine organism, as
reflected by weights of the whole body, liver, lung, kidney or
prostate, did not uncover major untoward effects. The only
unusual effect was a small increase in kidney weight associated
with a slight increase in tubular lipid, content but without
associated degenerative alterations. We also discovered that livers
in TRAMP mice are slightly but significantly smaller than those in
their wild-type counterparts, a phenomenon that has not been
reported thus far. One may speculate that prostate tumours secrete
agents that specifically retard liver weight gain.
Correlations between rodent and human data are imperfect with
respect to chemopreventive efficacy and safety. Nevertheless, a
retrospective analysis of results in rodents and humans, obtained
with inhibitors of COX enzymes in colorectal cancer prevention,
shows reasonable consistency (Hawk and Levin, 2005). The Apc
Min
mouse model predicted the adenoma-regressing activity of the
NSAID sulindac and the COX-2 inhibitor celecoxib (Boolbol et al,
1996; Jacoby et al, 2000) in familial adenomatous polyposis coli
patients (Giardiello et al, 1993; Steinbach et al, 2000). Unwanted
side effects of NSAIDs and of COX-2 inhibitors, the latter of which
have recently received considerable attention (Fitzgerald, 2004),
may ultimately militate against their extensive use as cancer
chemopreventive agents in humans. Therefore, the search for
toxicologically innocuous alternative interventions is timely and
propitious, and foodstuffs provide an attractive focus for this
search. In the light of the safety of rice bran and its efficacy in the
Apc
Min mouse described here, as well as in carcinogen-induced rat
models of colorectal cancer (Kawabata et al, 1999; Katayama et al,
2002; Shimoji et al, 2004), we suggest that rice bran might be
worthy of consideration for clinical evaluation as an intervention
to prevent adenoma recurrence. In contrast, our results in two
genetic models of mammary and prostate cancer do not support
the inclusion of rice bran in the portfolio of candidate interven-
tions for clinical development in the chemoprevention of breast or
prostate cancer.
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